| 767078 |
FRONTIERS IN GENETICS |
Role of Non-Coding RNAs in Post-Transcriptional Regulation of Lung Diseases |
2021-11-08 |
10.3389/fgene.2021.767348 |
Soni Dharmendra Kumar, Biswas Roopa |
| 767077 |
FRONTIERS IN GENETICS |
Omics Technologies to Enhance Plant Based Functional Foods: An Overview |
2021-11-08 |
10.3389/fgene.2021.742095 |
Nayak Spurthi N., Aravind B., Malavalli Sachin S., Sukanth B. S., Poornima R., Bharati Pushpa, Hefferon Kathleen, Kole Chittaranjan, Puppala Naveen |
| 767076 |
FRONTIERS IN GENETICS |
Prognostic Model and Nomogram Construction Based on a Novel Ferroptosis-Related Gene Signature in Lower-Grade Glioma |
2021-11-08 |
10.3389/fgene.2021.753680 |
Zhao Junsheng, Liu Zhengtao, Zheng Xiaoping, Gao Hainv, Li Lanjuan |
| 767075 |
FRONTIERS IN GENETICS |
The Use of ‘Omics for Diagnosing and Predicting Progression of Chronic Kidney Disease: A Scoping Review |
2021-11-08 |
10.3389/fgene.2021.682929 |
Govender Melanie A., Brandenburg Jean-Tristan, Fabian June, Ramsay Michèle |
| 767074 |
FRONTIERS IN ONCOLOGY |
Persistent Response to a Combination Treatment Featuring a Targeted Agent and an Immune Checkpoint Inhibitor in a Patient With Collecting Duct Renal Carcinoma: A Case Report and Literature Review |
2021-11-08 |
10.3389/fonc.2021.764352 |
Zhou Weimin, Huang Ji, He Qiuming, Luo Qingfeng, Zhang Xiaofang, Tao Xuewei, Dong Hanzhi, Tu Xinhua |
| 767073 |
FRONTIERS IN ONCOLOGY |
Development and Internal Validation of a Preoperative Prediction Model for Sentinel Lymph Node Status in Breast Cancer: Combining Radiomics Signature and Clinical Factors |
2021-11-08 |
10.3389/fonc.2021.754843 |
Wang Chunhua, Chen Xiaoyu, Luo Hongbing, Liu Yuanyuan, Meng Ruirui, Wang Min, Liu Siyun, Xu Guohui, Ren Jing, Zhou Peng |
| 767072 |
FRONTIERS IN ONCOLOGY |
Monitoring and Managing BTK Inhibitor Treatment-Related Adverse Events in Clinical Practice |
2021-11-08 |
10.3389/fonc.2021.720704 |
O’Brien Susan M., Brown Jennifer R., Byrd John C., Furman Richard R., Ghia Paolo, Sharman Jeff P., Wierda William G. |
| 767071 |
FRONTIERS IN ONCOLOGY |
Prognostic Value of Baseline Medications Plus Neutrophil-to-Lymphocyte Ratio in the Effectiveness of Nivolumab and Pembrolizumab in Patients With Advanced Non-Small-Cell Lung Cancer: A Retrospective Study |
2021-11-08 |
10.3389/fonc.2021.770268 |
Ogiwara Toshiki, Kawazoe Hitoshi, Egami Saeka, Hashimoto Hironobu, Saito Yoshimasa, Sakiyama Naomi, Ohe Yuichiro, Yamaguchi Masakazu, Furukawa Tetsuya, Hara Azusa, Hiraga Yui, Jibiki Aya, Yokoyama Yuta, Suzuki Sayo, Nakamura Tomonori |
| 767070 |
FRONTIERS IN ONCOLOGY |
Sintilimab and Chidamide for Refractory Transformed Diffuse Large B Cell Lymphoma: A Case Report and A Literature Review |
2021-11-08 |
10.3389/fonc.2021.757403 |
Chen Chao, Zhang Wei, Zhou Daobin, Zhang Yan |
| 767069 |
FRONTIERS IN ONCOLOGY |
Pulmonary Complications in Children Following Hematopoietic Cell Transplantation: A Case Report and Review of the Diagnostic Approach |
2021-11-08 |
10.3389/fonc.2021.772411 |
Elbahlawan Lama, McArthur Jenny, Morin Cara E., Abdelhafeez Hafeez, McCarville M. Beth, Ruiz Robert E., Srinivasan Saumini, Qudeimat Amr |
